Mazen Animal Health announced this week the closing of its Series A round of over $11 million. The round was led by Fall Line Capital and joined by all previous seed investors including Next Level Ventures, ISA Ventures, Kent Corporation, Ag Startup Engine, Ag Ventures Alliance Summit Ag. New investors, AgFunder, 1330 Investments, Addison Laboratories, SLO Seeds Ventures and Cal Poly Ventures also participated in the financing.
The company is developing orally-delivered animal vaccines that revolutionize animal disease prevention. By administering the vaccine with feed, Mazen eliminates the challenges associated with finding labor to administer injectable vaccines and other issues such as broken needles in the animal or accidental vaccination of the worker. Oral vaccines allow for cost-effective disease prevention with improved animal welfare.
“I am thrilled to have Fall Line Capital lead our Series A round. They believe in our experienced team and transformational technology – and share our vision for aggressive growth,” said Jenny Filbey, CEO of Mazen. “I am also delighted to have all our Seed investors continue to support us both financially and in the community. We have a great group of investors.”
Mazen’s lead oral vaccine in development for the prevention of Porcine Epidemic Diarrhea Virus (PEDV) is currently undergoing pivotal efficacy studies required for USDA approval. The company is also scaling up commercial manufacture of the vaccine.
“Our investors are seeing the tremendous potential of the technology platform to deliver better vaccines more efficiently,” said Filbey. “In fact, the technology can help achieve better animal health through disease prevention – rather than. treatment – and improve economics, stewardship and sustainability.”
Mazen’s pipeline has advanced with ongoing proof-of-concept studies for coccidiosis in poultry and a third proprietary product in development, also for poultry. The Series A funds will be used to support launch of the PEDV product, development of pipeline products, addition of new products to the pipeline, as well as adding new members to the team.